George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksINTO.L Regulatory News (INTO)

  • There is currently no data for INTO

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Corporate Update

9 Aug 2021 07:00

RNS Number : 9298H
Intosol Holdings PLC
08 August 2021
 

 

 

 

 

INTOSOL HOLDINGS PLC.

Corporate Update

 

INTOSOL Holdings Plc. ("INTOSOL" or the "Company"), the award-winning international luxury travel Company, is pleased to provide an update and disclosure on a number of corporate matters.

Share trading volumes are extremely low compounded by a COVID-19 pandemic travel restrictions on key jurisdictions that the Company operates in. In the medium to longer term the Company’s revenue and the building up of its assets will address the low share trading distribution. An expansion of properties in particular South Africa that is exclusively managed by the Company has resulted in forward bookings for the winter season, particular in high-end regular clients. This transaction is not a fundamental change in the business but rather an expansion into the high-end bespoke travel business. The Company qualified for German government funding as a leading travel company to maintain staff and working capital during the COVID-19 pandemic. The Comanys head office, banking and operatons are based in Hamburg, Germany.

The Company has reviewed its advisor's performance in promoting the Company and terminated a number of engagements. The Company will continue to review and make changes to its relationships and advisors. These corporate actions have resulted in litigation against the Company which is normal course business in any corporation. The Company will only disclose litigation on judgement and/or when settlement negotiations has been fully exhausted to avoid frivolous disclosures. The Company has appointed a leading UK law firm to deal with any litigation and any judgments to the Company.

 

The Company advises that all regulatory and stock exchange fees and any other regulatory fees are up to date with no default.

 

For further information on INTOSOL visit the Company's website www.INTOSOLholdingsplc.com or contact:

Rainer Spekowius (CEO)

INTOSOL Holdings Plc

 

Tel: +49 (0) 171 911 31 05

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDDDGDIBGGDGBI
12
Date   Source Headline
5th May 20227:00 amRNSCorporate Update
20th Apr 20227:00 amRNSCorporate Update
13th Dec 202111:39 amRNSAgreement
12th Nov 20212:15 pmRNSResult of AGM
3rd Nov 202111:15 amRNSContract
28th Oct 20217:00 amRNSHalf-year Report
13th Oct 202111:21 amRNSNotice of AGM and Special Shareholder Meeting
9th Aug 20217:00 amRNSCorporate Update
30th Jul 20219:41 amRNSAnnual Financial Report
30th Oct 202011:03 amRNSResults of Annual General Meeting
29th Oct 20208:30 amRNSSix Month Interim Financial Statements
7th Oct 20207:00 amRNSAGM Statement
1st Sep 202012:50 pmRNSAnnual Financial Report
3rd Aug 20201:15 pmRNSTemporary Suspension Amended
3rd Aug 20201:06 pmRNSTemporary Suspension Amended
3rd Aug 202011:34 amRNSTemporary Suspension
3rd Aug 20207:30 amRNSSuspension - INTOSOL Holdings PLC
19th Nov 20192:45 pmPRNCorporate Update
14th Nov 20199:05 amRNSSecond Price Monitoring Extn
14th Nov 20199:00 amRNSPrice Monitoring Extension
31st Oct 20198:45 amPRNInterim results
23rd Oct 201911:05 amRNSSecond Price Monitoring Extn
23rd Oct 201911:00 amRNSPrice Monitoring Extension
14th Oct 20192:05 pmRNSSecond Price Monitoring Extn
14th Oct 20192:00 pmRNSPrice Monitoring Extension
4th Oct 201912:30 pmPRNResult of General Meeting
1st Oct 20192:05 pmRNSSecond Price Monitoring Extn
1st Oct 20192:00 pmRNSPrice Monitoring Extension
25th Sep 20192:05 pmRNSSecond Price Monitoring Extn
25th Sep 20192:00 pmRNSPrice Monitoring Extension
25th Sep 20199:00 amPRNCompany Update
20th Sep 201911:48 amRNSSecond Price Monitoring Extn
20th Sep 201911:47 amRNSPrice Monitoring Extension
19th Sep 20192:05 pmRNSSecond Price Monitoring Extn
19th Sep 20192:00 pmRNSPrice Monitoring Extension
22nd Jul 20194:18 pmPRNPCA Shareholding
18th Jul 20191:20 pmPRNClarification - First Tranche Payment for Oceans
16th Jul 20197:00 amPRNFirst Tranche Payment Completed for Oceans Wilderness
11th Jul 201912:18 pmPRNResult of AGM
2nd Jul 20192:06 pmRNSSecond Price Monitoring Extn
2nd Jul 20192:00 pmRNSPrice Monitoring Extension
25th Jun 20197:00 amPRNDevelopment of Proprietary Travel Design Technology
19th Jun 201911:05 amRNSSecond Price Monitoring Extn
19th Jun 201911:00 amRNSPrice Monitoring Extension
17th Jun 20191:30 pmPRNNotice of AGM
17th Jun 20197:00 amPRNTrading Update
31st May 20195:30 pmPRNFinal Results
29th May 201912:00 pmPRNFinal Purchase Contract for Flagship Hotel Signed
22nd Mar 20197:00 amPRNBoutique Hotel in South Africa Strengthens Portfolio
20th Mar 20197:00 amPRNAppointment of Broker
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.